Quflora Pediatric Tablet, Chewable
Pricing Report NDC 15370-104-30

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The latest wholesale acquisition cost for Quflora Pediatric (NDC 15370-104-30) is $6.14171 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 13, 2018.

As a a human prescription drug provided by Carwin Pharmaceutical Associates, Llc, this medication is distributed in a 30 TABLET, CHEWABLE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$6.14171
Per EA

Effective Date
Apr 13, 2018
Billable Units
30 EA
Estimated Package Price
$184.25
Data Status
As of Jun 06, 2018
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET, CHEWABLE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2015, the NADAC wholesale price for (NDC ) has moved within a range of $5.14380 to $6.14171 per EA. Over this 2 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.1438 - $6.1417
Market Volatility
19.40% Variance
Latest Trend
9.50%
Date Unit Price Unit Source Method Rate
Apr 13, 2018 $6.14171 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Apr 13, 2018 $6.14171 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Jan 17, 2018 $5.60887 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 17, 2018 $5.60887 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Apr 20, 2016 $5.65823 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Apr 20, 2016 $5.65823 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Dec 23, 2015 $5.14380 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 23, 2015 $5.14380 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026